Inovio Pharmaceuticals
INO
#9510
Rank
A$0.18 B
Marketcap
A$1.77
Share price
0.40%
Change (1 day)
-53.08%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -A$0.14 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.13 Billion, an increase over its 2024 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.14 Billion3.6%
2025 -A$0.13 Billion-15.67%
2024 -A$0.15 Billion-20.03%
2023 -A$0.19 Billion-51.56%
2022 -A$0.39 Billion-8.26%
2021 -A$0.43 Billion95.4%
2020 -A$0.22 Billion36.62%
2019 -A$0.16 Billion20.19%
2018 -A$0.14 Billion10.94%
2017 -A$0.12 Billion9.59%
2016 -A$0.11 Billion118.9%
2015 -A$49.29 Million-10.67%
2014 -A$55.17 Million83.32%
2013 -A$30.1 Million
2011 -A$31.05 Million15.64%
2010 -A$26.85 Million37.7%
2009 -A$19.5 Million2.19%
2008 -A$19.08 Million-14.09%
2007 -A$22.21 Million19.12%
2006 -A$18.65 Million9.62%
2005 -A$17.01 Million5.77%
2004 -A$16.08 Million73.08%
2003 -A$9.29 Million12.75%
2002 -A$8.24 Million
2000 -A$12.48 Million53.93%
1999 -A$8.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.28 B-29,892.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.04 B-18,200.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.79 B-12,245.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.98 B-12,402.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.37 B-15,182.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.98 B-11,580.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-A$3.85 Million-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-A$0.23 Billion 83.29%๐Ÿ‡บ๐Ÿ‡ธ USA